Health in Panama 311 indicators covering health for Panama. IndicatorLatest Year10-yr change Rank Population ages 80 and above, female 58,072 2025 up 68.6% 103rd Population ages 80 and above, male 37,189 2025 up 74.7% 99th Prevalence of overweight, weight for height, female 10.1% 2024 down 3.8% 30th Prevalence of overweight, weight for height, male 11.5% 2024 down 4.2% 30th Prevalence of overweight, weight for height 10.9% 2024 down 3.5% 28th Prevalence of stunting, height for age, female 12.7% 2024 down 26.6% 73rd Prevalence of stunting, height for age, male 15.3% 2024 down 26.1% 72nd Prevalence of stunting, height for age 14.0% 2024 down 26.3% 72nd Hospital beds 1.95 per 1,000 people 2023 down 8.5% 98th Tuberculosis death rate 4.1 per 100,000 people 2024 down 26.8% 92nd Incidence of tuberculosis 63 per 100,000 people 2024 up 21.2% 80th People using at least basic drinking water services, urban 98.5% 2024 up 0.7% 85th People using at least basic sanitation services, urban 96.9% 2024 up 11.7% 76th People practicing open defecation, urban 0.2% 2024 down 76.2% 74th People using at least basic drinking water services, rural 87.8% 2024 up 6.2% 104th People using at least basic sanitation services, rural 70.8% 2024 up 19.7% 110th People using at least basic drinking water services 95.3% 2024 up 2.8% 130th People practicing open defecation, rural 9.8% 2024 down 26.7% 46th People using at least basic sanitation services 89.1% 2024 up 15.0% 129th Tuberculosis case detection rate 77.0% 2024 up 8.5% 89th People practicing open defecation 3.1% 2024 down 38.8% 59th Current health expenditure 8.3% 2023 up 27.7% 56th Current health expenditure per capita 1,558 current US$ 2023 up 93.3% 50th Out-of-pocket expenditure 40.5% 2023 up 25.3% 57th Out-of-pocket expenditure per capita 630.21 current US$ 2023 up 142.3% 31st Domestic general government health expenditure 51.2% 2023 down 18.1% 107th Domestic general government health expenditure per capita, PPP 1,700 current international $ 2023 up 88.8% 57th Domestic private health expenditure 48.0% 2023 up 28.8% 60th Healthcare spending vs. GDP per capita 3,318 current international $ 2023 up 130.5% 41st Domestic private health expenditure per capita 748.07 current US$ 2023 up 149.0% 34th Immunization, Hib3 72.0% 2024 down 10.0% 160th Child mortality vs. average years of schooling for women 1.53 deaths per 100 live births 2024 down 11.7% 98th Reported cases of measles 0 Cases 2024 — 146th Child mortality by income level of country 1.53 deaths per 100 live births 2024 down 11.7% 98th Number of infant deaths 855 2024 down 20.5% 112th Number of under-five deaths 1,092 2024 down 19.0% 109th Number of neonatal deaths 379 2024 down 34.0% 119th Child mortality vs. health spending 1.53 deaths per 100 live births 2024 down 11.7% 98th Share of one-year-olds vaccinated against measles 93.0% 2024 up 3.3% 76th Adolescent fertility rate 55.85 births per 1,000 women ages 15-19 2024 down 38.1% 58th Sex ratio at birth 1.05 male births per female births 2024 down 0.3% 90th Domestic general government health expenditure 19.8% 2023 up 14.1% 11th External health expenditure 0.8% 2023 up 302.1% 108th External health expenditure per capita 11.86 current US$ 2023 up 677.4% 59th External health expenditure per capita, PPP 25.27 current international $ 2023 up 827.0% 73rd Prevalence of anemia among women of reproductive age 25.5% 2023 up 13.3% 96th Prevalence of anemia among non-pregnant women 25.4% 2023 up 13.9% 97th Prevalence of anemia among pregnant women 27.5% 2023 up 3.4% 97th Stillbirth rate 6.6 per 1,000 total births 2023 up 13.8% 114th Children orphaned by HIV/AIDS 11,000 2024 up 11.1% 58th Life expectancy vs. health spending 79.59 years 2023 up 3.2% 61st Prevalence of undernourishment 5.7% 2023 down 19.7% 80th Immunization, measles second dose 82.0% 2024 down 8.9% 98th Antiretroviral therapy coverage 67.0% 2024 up 67.5% 86th Tuberculosis treatment success rate 75.0% 2023 down 6.2% 140th Prevalence of hypertension, female 35.3% 2019 up 0.6% 119th Prevalence of hypertension, male 36.8% 2019 down 0.8% 100th Prevalence of hypertension 36.1% 2019 unchanged 109th Treatment for hypertension, female 63.9% 2019 up 15.6% 30th Treatment for hypertension, male 45.7% 2019 up 30.6% 53rd ← Previous Page 4 of 6 Next →